[Treatment of asthenic disorders with tanakan].

AIM: To evaluate efficacy and safety of tanakan in different asthenic disorders.

MATERIAL AND

METHODS

Tanakan in a dose 240 mg/day was used in 60 patients with various asthenic disorders arising in neurasthenia and late after craniocerebral trauma. The response was assessed by the scale of general clinical impression, side effects and by changes in psychic and somatic status.

RESULTS

The response was achieved in 90% of the patients. 78% had significant improvement regardless nosological entity of asthenia.

CONCLUSION

Tanakan is safe and effective in therapy of asthenic disorders. Moreover, with tanakan asthenia can be treated without polypragmasia.